Clinical Trial Update: Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial of gevokizumab for active non-infectious uveitis was terminated, indicating the study did not proceed to completion as planned.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis
• Uveitis

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: XOMA (US) LLC | Conditions: Uveitis | Phase 3 | Status: TERMINATED